Total Funding
21
53
Total FundingSeries D raised
Growth Score
1 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
177386
EOFlow provides user friendly, smart wearable drug delivery solutions.
- Jesse J. Kim: Founder & CEO
- Ian Welsford: Chief Compliance officer
About the Company
EOFlow has launched EOPatch, the world’s smallest full-featured wearable, disposable insulin pump. EOPatch wearable insulin pump is smarter, better-connected, and lasts longer than the current market leader, yet costs less. The company will offer a software upgrade to enable closed-loop insulin control ('artificial pancreas' or
'automated insulin delivery') on the current system. It is also developing an all-in-one wearable disposable artificial pancreas solution, which was recently given a Breakthrough Device designation by FDA.
